메뉴 건너뛰기
Drugs
Volumn 55, Issue SUPPL. 1, 1998, Pages 1-9
The significance of continuous dopaminergic stimulation in the treatment of Parkinson's disease
Author keywords

[No Author keywords available]
Indexed keywords

ANTIPARKINSON AGENT; DOPAMINE; GLUTAMATE RECEPTOR; LEVODOPA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;
EID: 0031976069     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199855001-00001     Document Type: Conference Paper
Times cited : (165)
References (10)
  • 1
    • 0029269229 scopus 로고
    • The rationale for the use of dopamine agonists in Parkinson's disease
    • Jenner P. The rationale for the use of dopamine agonists in Parkinson's disease. Neurology 1995; 45 Suppl. 3: S6-12
    • (1995) Neurology , vol.45 , Issue.3 SUPPL.
    • Jenner, P.1
  • 2
    • 0015745743 scopus 로고
    • Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations
    • Bernheimer H, Birkmayer W, Hornykiewicz O, et al. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 1973; 20: 415-55
    • (1973) J Neurol Sci , vol.20 , pp. 415-455
    • Bernheimer, H.1    Birkmayer, W.2    Hornykiewicz, O.3
  • 3
    • 0027496673 scopus 로고
    • Differential effect of selective D1 and D2 dopamine receptor agonists on levodopa-induced dyskinesia in l-methyl-4-phenyl-l,2,3,6-tetrahydropyridine-exposed monkeys
    • Blanchet P, Bedard PJ, Britton DR, et al. Differential effect of selective D1 and D2 dopamine receptor agonists on levodopa-induced dyskinesia in l-methyl-4-phenyl-l,2,3,6-tetrahydropyridine-exposed monkeys. J Pharmacol Exp Ther 1993; 267: 275-9
    • (1993) J Pharmacol Exp Ther , vol.267 , pp. 275-279
    • Blanchet, P.1    Bedard, P.J.2    Britton, D.R.3
  • 4
    • 0027369564 scopus 로고
    • Relative potency and efficacy of some dopamine agonists with varying selectivities for Dl and D2 receptors in MPTP-induced hemiparkinsonian monkeys
    • Domino EF, Sheng J. Relative potency and efficacy of some dopamine agonists with varying selectivities for Dl and D2 receptors in MPTP-induced hemiparkinsonian monkeys. J Pharmacol Exp Ther 1993; 265: 1387-91
    • (1993) J Pharmacol Exp Ther , vol.265 , pp. 1387-1391
    • Domino, E.F.1    Sheng, J.2
  • 5
    • 0030001780 scopus 로고    scopus 로고
    • Oxidative stress and antioxidant therapy in Parkinson's disease
    • Ebadi M, Srinivasan SK, Baxi MD. Oxidative stress and antioxidant therapy in Parkinson's disease. Prog Neurobiol 1996; 48(1): 1-19
    • (1996) Prog Neurobiol , vol.48 , Issue.1 , pp. 1-19
    • Ebadi, M.1    Srinivasan, S.K.2    Baxi, M.D.3
  • 6
  • 7
    • 0029751104 scopus 로고    scopus 로고
    • Oxidative stress and the pathogenesis of Parkinson's disease
    • Jenner P, Olanow CW. Oxidative stress and the pathogenesis of Parkinson's disease. Neurology 1996; 47 Suppl. 3: S161-70
    • (1996) Neurology , vol.47 , Issue.3 SUPPL.
    • Jenner, P.1    Olanow, C.W.2
  • 9
    • 0030897345 scopus 로고    scopus 로고
    • Attenuation of levodopa-induced toxicity in mesencephalic cultures by pramipexole
    • Carvey PM, Pieri S, Ling ZD. Attenuation of levodopa-induced toxicity in mesencephalic cultures by pramipexole. J Neural Transm 1997; 104: 209-28
    • (1997) J Neural Transm , vol.104 , pp. 209-228
    • Carvey, P.M.1    Pieri, S.2    Ling, Z.D.3
  • 10
    • 0028470918 scopus 로고
    • Palliative and prophylactic benefits of continuously administered dopaminomimetics in Parkinson's disease
    • Chase TN, Engber TM, Mouradian MM. Palliative and prophylactic benefits of continuously administered dopaminomimetics in Parkinson's disease. Neurology 1994; 44 Suppl. 6: S15-18
    • (1994) Neurology , vol.44 , Issue.6 SUPPL.
    • Chase, T.N.1    Engber, T.M.2    Mouradian, M.M.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.